• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Risk for Chronic Health Conditions Increased for Young LGB Cancer Survivors

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 4, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Dec. 4, 2023 -- The risk for chronic health conditions is increased for lesbian, gay, and bisexual (LGB) adolescent and young adult cancer survivors (AYACS) compared with LGB individuals without a history of cancer and heterosexual AYACS, according to a study published online Dec. 4 in Cancer.

Amy M. Berkman, M.D., from the Duke University School of Medicine in Durham, North Carolina, and colleagues examined the extent to which sexual orientation is associated with excess burden of chronic conditions in AYACS. Data were included for 170 LGB AYACS; 1,700 LGB individuals without a history of cancer; and 1,700 heterosexual AYACS.

LGB survivors were less likely than heterosexual survivors to be married and were more likely to have never been married. The researchers found that compared with LGB individuals without a history of cancer and heterosexual survivors, LGB survivors were more likely to have incomes between 100 and 200 percent of the federal poverty level and were less likely to report incomes above 200 percent of the federal poverty level. The odds of chronic health conditions were higher for LGB survivors than LGB individuals without a history of cancer and heterosexual survivors (odds ratios, 2.45 and 2.16, respectively).

"This study highlights significant health disparities that affect the LGB cancer survivor community and points to the need for specialized care and attention for these individuals during and after their cancer treatment to address their heightened risk of chronic health issues," lead author Michael E. Roth, M.D., of The University of Texas MD Anderson Cancer Center in Houston, said in a statement. "This could hopefully lead to more equitable health care for sexual and gender minority populations."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted December 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.